trial
as of 2026-07-01Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
NCTId NCT04338152
at a glance
— · Active Not Recruiting
Enrollment 220 (estimated)
Primary completion 2026-12-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Active Not Recruiting
Enrollment
220 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-01-15
Primary completion
2026-12-30
Eligibility
ALL · 13 Years · 25 Years
Interventions & indications
Sponsors
Investigators
10
David J. Miklowitz, Ph.D.Principal Investigator
Carrie E. Bearden, Ph.D.Principal Investigator
Kristin S. Heiervang, Ph.D.Principal Investigator
Scott Woods, M.D.Principal Investigator
Jean M. Addington, Ph.D.Principal Investigator
Michelle S. Friedman-Yakoobian, Ph.D.Principal Investigator
Andrea M. Auther, Ph.D.Principal Investigator
Barbara A. Cornblatt, Ph.D., M.B.A.Principal Investigator
Daniel H. Mathalon, Ph.D., M.D.Principal Investigator
Holly K. Hamilton, Ph.D.Principal Investigator
Sites
7 total
Los Angeles, United StatesSan Diego, United StatesSan Francisco, United StatesNew Haven, United StatesBoston, United StatesNew York, United StatesCalgary, Canada
Facts & assertions
4 sourced
Enrollment
220
Phase
NA
Primary Completion Date
2026-12-30
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
lead_sponsor
collaborator
indication
indication
indication
indication
investigator
person
person